Pinned post
The PCCTC is now posting on Bluesky. Follow us there for innovative prostate cancer clinical trials updates: bsky.app/profile/thepcc…
The PCCTC
@ThePCCTC
The Prostate Cancer Clinical Trials Consortium (PCCTC) translates scientific discoveries to improved standards of care.
807 Following 1.5K Followers 2K Posts
Latest posts 5
📷
The PCCTC-managed @PCaPROMISE Registry will add to our understanding of how genetic differences affect patient outcomes, help family members understand their own risk of cancer, and guide discovery of new personalized treatments. To learn more visit prostatecancerpromise.org
The PCCTC-managed @PCaPROMISE Registry will add to our understanding of how genetic differences affect patient outcomes, help family members understand their own risk of cancer, and guide discovery of new personalized treatments. To learn more visit prostatecancerpromise.org
We are pleased to announce our Summer 2025 internships in Data Management, Data Science, and Clinical Operations. Please direct anyone you know who is pursuing a career in clinical research or other health professions to the following link for more info
linkedin.com/posts/prostate…
linkedin.com/posts/prostate…
www.linkedin.com PCCTC Data Management Internship, Remote in | Careers at Remote | The Prostate Cancer Clinical... The Prostate Cancer Clinical Trials Consortium (PCCTC) is pleased to announce its Summer 2025 internships. Opportunities are available in Data Management, Data Science, and Clinical Operations. To... PCCTC investigators and colleagues collaborate on Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer (JCO Oncol Pract) pubmed.ncbi.nlm.nih.gov/39700441/
PCCTC investigator Evan Y. Yu, MD (@UWDeptMedicine) discusses therapeutic goals of newly diagnosed metastatic hormone-sensitive prostate cancer via @TargetedOnc: targetedonc.com/view/newly-dia…
www.targetedonc.com Newly diagnosed Diagnosed mHSPC: Goals of Therapy | Targeted Onc - Immunotherapy, Biomarkers, and... Evan Y. Yu, MD, discusses how the goals of therapy for a patient with newly- diagnosed metastatic hormone-sensitive prostate cancer are to control disease progression, extend survival, maintain...